BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23653275)

  • 1. Hyperandrogenism in adolescent girls with type 1 diabetes mellitus treated with intensive and continuous subcutaneous insulin therapy.
    Zachurzok A; Deja G; Gawlik A; Drosdzol-Cop A; Małecka-Tendera E
    Endokrynol Pol; 2013; 64(2):121-8. PubMed ID: 23653275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Prevalence of Polycystic Ovary Syndrome in Type 1 Diabetes Mellitus Adolescents: Is There a Difference Depending on the NIH and Rotterdam Criteria?
    Busiah K; Colmenares A; Bidet M; Tubiana-Rufi N; Levy-Marchal C; Delcroix C; Jacquin P; Martin D; Benadjaoud L; Jacqz-Aigrain E; Laborde K; Robert JJ; Samara-Boustani D; Polak M
    Horm Res Paediatr; 2017; 87(5):333-341. PubMed ID: 28437788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of polycystic ovary syndrome and its clinical and hormonal profile in young females with type 1 diabetes mellitus: experience from a teaching institution of India.
    Dominic N; Sharma L; Mohindra N; Dabadghao P
    Endocrine; 2023 Nov; 82(2):303-310. PubMed ID: 37615813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian hyperandrogenism in adolescents and young women with type I diabetes is primarily related to birth weight and body mass index.
    Bizzarri C; Benevento D; Ravà L; Patera IP; Schiaffini R; Ciampalini P; Giannone G; Cappa M
    Fertil Steril; 2011 Dec; 96(6):1497-1502.e1. PubMed ID: 21982726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Influence of Prepubertal Onset of Type 1 Diabetes and Age of Menarche on Polycystic Ovary Syndrome Diagnosis.
    Łebkowska A; Adamska A; Krentowska A; Uruska A; Rogowicz-Frontczak A; Araszkiewicz A; Ożegowska K; Hryniewicka J; Leśniewska M; Wender-Ożegowska E; Zozulińska-Ziółkiewicz D; Kowalska I
    J Clin Endocrinol Metab; 2021 May; 106(6):1811-1820. PubMed ID: 33537700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperandrogenism in adolescent girls: relationship with the somatotrophic axis.
    Hernandez MI; López P; Gaete X; Villarroel C; Cavada G; Avila A; Iñiguez G; Cassorla F
    J Pediatr Endocrinol Metab; 2017 May; 30(5):561-568. PubMed ID: 28593921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of body mass index on measured and calculated androgen parameters in adult women with Hirsutism and PCOS.
    Cupisti S; Dittrich R; Binder H; Kajaia N; Hoffmann I; Maltaris T; Beckmann MW; Mueller A
    Exp Clin Endocrinol Diabetes; 2007 Jun; 115(6):380-6. PubMed ID: 17701884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of polycystic ovarian changes and polycystic ovary syndrome in premenopausal women with treated type 2 diabetes mellitus.
    Kelestimur F; Unluhizarci K; Baybuga H; Atmaca H; Bayram F; Sahin Y
    Fertil Steril; 2006 Aug; 86(2):405-10. PubMed ID: 16762349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of the polycystic ovary syndrome and hirsutism in women with type 1 diabetes mellitus.
    Escobar-Morreale HF; Roldán B; Barrio R; Alonso M; Sancho J; de la Calle H; García-Robles R
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4182-7. PubMed ID: 11095451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Fetuin-A levels, insulin resistance and oxidative stress in women with polycystic ovary syndrome.
    Enli Y; Fenkci SM; Fenkci V; Oztekin O
    Gynecol Endocrinol; 2013 Dec; 29(12):1036-9. PubMed ID: 23961784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperandrogenemia association with acne and hirsutism severity in Croatian women with polycystic ovary syndrome.
    Pavičić Baldani D; Škrgatić L; Bukvić Mokos Z; Trgovčić I
    Acta Dermatovenerol Croat; 2013; 21(2):105-12. PubMed ID: 24001418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Menstrual Disorders and Androgen-Related Traits in Young Women with Type 1 Diabetes Mellitus: a Clinical Study.
    Paschou SA; Vryonidou A; Melissourgou M; Kosteria I; Goulis D; Chrousos GP; Kanaka-Gantenbein C
    Endocr Pract; 2020 Nov; 26(11):1269-1276. PubMed ID: 33471656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectrum of metabolic dysfunction in relationship with hyperandrogenemia in obese adolescent girls with polycystic ovary syndrome.
    Alemzadeh R; Kichler J; Calhoun M
    Eur J Endocrinol; 2010 Jun; 162(6):1093-9. PubMed ID: 20371657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of hirsutism and menstrual disorders in obese adolescent girls and adolescent girls with type 1 diabetes mellitus despite different hormonal profiles.
    Samara-Boustani D; Colmenares A; Elie C; Dabbas M; Beltrand J; Caron V; Ricour C; Jacquin P; Tubiana-Rufi N; Levy-Marchal C; Delcroix C; Martin D; Benadjaoud L; Jacqz Aigrain E; Trivin C; Laborde K; Thibaud E; Robert JJ; Polak M
    Eur J Endocrinol; 2012 Feb; 166(2):307-16. PubMed ID: 22127492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Exploration of the classification of polycystic ovarian syndrome].
    Lin JF; Li X; Zhu MW
    Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hormonal phenotype of Nonclassic 3 beta-hydroxysteroid dehydrogenase (HSD3B) deficiency in hyperandrogenic females is associated with insulin-resistant polycystic ovary syndrome and is not a variant of inherited HSD3B2 deficiency.
    Carbunaru G; Prasad P; Scoccia B; Shea P; Hopwood N; Ziai F; Chang YT; Myers SE; Mason JI; Pang S
    J Clin Endocrinol Metab; 2004 Feb; 89(2):783-94. PubMed ID: 14764797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and endocrinological effects of 6 months of metformin treatment in young hyperinsulinemic patients affected by polycystic ovary syndrome.
    Loverro G; Lorusso F; De Pergola G; Nicolardi V; Mei L; Selvaggi L
    Gynecol Endocrinol; 2002 Jun; 16(3):217-24. PubMed ID: 12192894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H; Tanir HM; Yildiz Z
    Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polycystic ovary syndrome (PCOS) and the accompanying disorders of glucose homeostasis among girls at the time of puberty.
    Otto-Buczkowska E; Grzyb K; Jainta N
    Pediatr Endocrinol Diabetes Metab; 2018; 24(1):40-44. PubMed ID: 30083660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and metabolic features of polycystic ovary syndrome among Chinese adolescents.
    Li L; Chen X; He Z; Zhao X; Huang L; Yang D
    J Pediatr Adolesc Gynecol; 2012 Dec; 25(6):390-5. PubMed ID: 23089573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.